MediNice SA (ICE) Stock Statistics & Valuation Metrics
Total Valuation
MediNice SA has a market cap or net worth of PLN 527.81M. The enterprise value is PLN 550.23M.
- Market Cap
- PLN 527.81M
- Enterprise Value
- PLN 550.23M
Share Statistics
MediNice SA has 10,451,639 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,451,639
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
MediNice SA’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -7.39%.
- Return on Equity (ROE)
- -0.08
- Return on Assets (ROA)
- -0.07
- Return on Invested Capital (ROIC)
- -7.39%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 0
- Profits Per Employee
- -560.25K
- Employee Count
- 12
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of MediNice SA is -54.33. MediNice SA’s PEG ratio is 0.48.
- PE Ratio
- -54.33
- PS Ratio
- 0.00
- PB Ratio
- 5.39
- Price to FCF
- -60.19
- Price to Operating Cash Flow
- -76.84
- PEG Ratio
- 0.48
Income Statement
In the last 12 months, MediNice SA had revenue of 0 and earned -6.72M in profits. Earnings per share was -0.80.
- Revenue
- 0
- Gross Profit
- -166.00K
- Operating Income
- -6.78M
- Pretax Income
- -6.74M
- Net Income
- -6.72M
- EBITDA
- -6.45M
- Earnings Per Share (EPS)
- -0.80
Cash Flow
In the last 12 months, operating cash flow was -5.91M and capital expenditures -3.35M, giving a free cash flow of -8.49M billion.
- Operating Cash Flow
- -5.91M
- Free Cash Flow
- -8.49M
- Free Cash Flow per Share
- -0.91
Dividends & Yields
MediNice SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.66%
- Earnings Yield
- -1.75%
Stock Price Statistics
- Beta
- 0.05
- 52-Week Price Change
- 340.66%
- 50-Day Moving Average
- 58.01
- 200-Day Moving Average
- 63.19
- Relative Strength Index (RSI)
- 35.73
- Average Volume (3m)
- 27.42K
Important Dates
MediNice SA upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 24, 2027
- Ex-Dividend Date
- ―
Financial Position
MediNice SA as a current ratio of 6.87, with Debt / Equity ratio of 0.41%
- Current Ratio
- 6.87
- Quick Ratio
- 6.87
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.43
- Interest Coverage Ratio
- -161.36
Taxes
In the past 12 months, MediNice SA has paid -14.00K in taxes.
- Income Tax
- -14.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
MediNice SA EV to EBITDA ratio is -67.26, with an EV/FCF ratio of -59.76.
- EV to Sales
- 0.00
- EV to EBITDA
- -67.26
- EV to Free Cash Flow
- -59.76
- EV to Operating Cash Flow
- -85.86
Balance Sheet
MediNice SA has PLN 4.17M in cash and marketable securities with PLN 503.00K in debt, giving a net cash position of PLN 3.67M billion.
- Cash & Marketable Securities
- PLN 4.17M
- Total Debt
- PLN 503.00K
- Net Cash
- PLN 3.67M
- Net Cash Per Share
- PLN 0.35
- Tangible Book Value Per Share
- PLN 0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for MediNice SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- -120.52%
